Francesco Peri

22PUBLICATIONS
33CO-AUTHORS
Biologically active moleculesMedical molecular engineering of nucleic acids and proteinsInnate immunityPowder and particle technologyBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 19, 2025
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives.

Federico Lami, Alessio Romerio, Laura Valle-Gómez

|Mar 25, 2025
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge.

Maite Sainz-Mejías, Chaoying Ma, Yueran Hou

|Mar 24, 2025
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists.

Ana Rita Franco, Zaineh Aladailleh, Alessio Romerio

|Mar 04, 2025
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection.

Kari Ann Shirey, Alessio Romerio, Mohammed Monsoor Shaik

|Dec 08, 2024
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant.

Mohammed Monsoor Shaik, Samuel Pasco, Alessio Romerio

|Mar 21, 2024
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies.

Ana Rita Franco, Océane Sadones, Alessio Romerio

Pageof 4

Frequent Collaborators

3 joint publications

Fabio Alessandro Facchini

3 joint publications

Samuel T Pasco

3 joint publications

Sonsoles Martin-Santamaria

3 joint publications

Valentina Artusa